可能因为您的浏览器不支持样式,您可以更新您的浏览器到最新版本,以获取对此功能的支持,访问下面的网站,获取关于浏览器的信息:
[1] Zidovetzki P, Wang JL, Kim JA, et al. Endothelin-1 enhances plasminogen activator inhibitor-1 production by human brain endothelial cells via protein kinase C-dependent pathway [J] .Atheroscler Thromb Vasc Biol, 1999, 19:1768.
[2] Hojo Y, Ikeda U, Katsuki T, et al. Release of endothelin 1 and angiotensin II induced by percutaneous transluminal coronary angioplasty [J] . Catheter Cardiovasc Interv, 2000, 51(1):42.
[3] Nakamura S, Nakamura I, Ma L, et al. Plasminogen activator inhibitor-1 expression is regulated by angiotensin type 1 receptor in vivo [J] . Kidney Int, 2000, 58(1):251.
[4] Marx N, Bourcier T, Sukhova GK, et al. PPAR γactivation in human endothelial cells increases plasminogen activator inhibitor type-1 expression. PPAR γ as apotential mediator in vascular diseases [J] . Arterioscler Thromb Vasc Biol, 1999, 19:546.
[5] Sjogren LS, Gan L, Doroudi R, et al. Fluid shear stress increases the intra-cellular storage pool of tissue-type plasminogen activator in intact human conduit vessels [J] . Thromb Haemost, 2000, 84(2):291.
[6] Osterland B, Holmgren A, Haggmark S, et al. Surgical stress induces acute coronary release of tissue-type plasminogen activator in the pig [J] . Acta Aneasthesiol Scand, 2000, 44(10):1226.
[7] Mussoni L, Banfi C, Sironi L, et al. Fluvastatin inhibits basal ands timulated plasminogen activator inhibitor 1, but induces tissue type plasminogen activator in cultured human endothelial cells [J] .Thromb Haemost, 2000, 84(1):59.
[8] Ishiwata S, Tukuda T, Nakanishi T, et al. Post angioplastic restenosis: platelet activation and the coagulation-fibrinolysis system as possible factors in the pathogenesis of restenosis [J] . Am Heart J, 1997, 133(4):387.
[9] Kawasaki T, Dewerchin M, Lijinen HR, et al. Vascular release of plasminogen activator inhibitor-1 impairs fibrinolysis during acute arterial thrombosis in mice [J] . Blood, 2000, 96(1):153.
[10] Kanamasa K, Ogawa I, Hayashi T, et al. Prevention of coronary arterial renarrowing by continuous 3-day in fusion of tissue plasminogen activator after successful percutaneous transluminal coronary angioplasty: a randomed, double-blind, placebo-controlled study [J] . Angiology, 2000, 51(5):367.
[11] 高炜, 霍勇, 朱国英, 等. 再狭窄的细胞和分子生物学(三) [J] . 中国介入心脏病学杂志, 1997, 5(4):180.
[12] Rerolle JP, Hertig A, Nguyen G, et al. Plasminogen activator inhibitor 1 is a potential target in renal fibrogenesis [J] . Kidney Int,2000,58(5):1841.
[13] Xiaoli M, Wenying H, Mingpeng S. Effects and mechanism of tissue-type plasminogen activator and plasminogen activator inhibitor on vascular smooth muscle cell proliferation [J] . Int J Cardiol, 1998, 66(Suppl1):S57.
[14] Strauss BH, Lau HK, Bowman KA, et al. Plasma urokinase antigen and plasminogen activator inhibitor-1 antigen levels predict angiographic coronary stenosis [J] . Circulation, 1999, 100:1616.